Navigation Links
Bionovo to Present at the Cowen and Company 31st Annual Healthcare Conference
Date:3/7/2011

EMERYVILLE, Calif., March 7, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that Dr. Isaac Cohen, O.M.D., Chairman and Chief Executive Officer, will be presenting at the Cowen and Company 31st Annual Healthcare Conference at 9:30 a.m. ET on Wednesday, March 9, 2011. The event will be held at the Boston Marriott Copley Place, in Boston, Massachusetts.

Interested parties can access a live audio webcast of the presentation by visiting http://www.wsw.com/webcast/cowen3/bnvi/. A replay of this webcast will also be available following the conference at http://bionovo.com/investors/events.

About Bionovo, Inc.

Bionovo, Inc. is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The Company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit: http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identif
'/>"/>

SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 2015  Giving people with low vision hope – ... International Academy of Low Vision Specialists (IALVS), ... at the forefront of low vision care. The academy ... and latest treatment options available to patients who present ... traditional means. Recently, doctors in six new states and ...
(Date:6/3/2015)... Va. , June 3, 2015  PARI Respiratory Equipment ... Pak ® .  Kitabis Pak, approved by the FDA on ... solution with a PARI LC PLUS ® Nebulizer for ... all the hard work we put into this unique product ... that is easy for patients to use, we also wanted ...
(Date:6/3/2015)...  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS ... today announced that it has entered into definitive ... approximately $13.6 million of securities in a registered ... such investors an aggregate of 2,469,091 shares of ... per share. The gross proceeds ...
Breaking Medicine Technology:International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 3International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 4Kitabis Pak Wins American Package Design Award 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 3
(Date:6/3/2015)... The National Resident Matching Program ... Savoia, M.D., Dean of Medical Education at the University of ... on July 1. , “It is an honor ... Matching Program,” said Dr. Savoia. “NRMP’s goal is to ... students with training programs, and I welcome the opportunity to ...
(Date:6/3/2015)... California (PRWEB) June 03, 2015 ... biopharmaceuticals or biologics has revolutionized disease treatment on account ... cancer and autoimmune diseases, such as rheumatoid arthritis. The ... the use of traditional small molecule drugs to biopharmaceuticals ... monoclonal antibodies (mAbs), cell and gene therapies, and recombinant ...
(Date:6/3/2015)... On June 22, 2015, Medicare will begin ... (pharmacogenetic) testing that it has reimbursed since 2009. , ... million of the 49 million Medicare beneficiaries in the U.S. ... drug events.(1) Sadly, if it became a standard of care, ... use of an individual’s genetic information to tailor treatment, is ...
(Date:6/3/2015)... On the heels of a report predicting ... 2020 ( click here to review news coverage about ... Baltimore has the talent to become a world-leading center ... and other biological data are collected and analyzed to help ... all the elements of a perfect storm for bioinformatics leadership,” ...
(Date:6/3/2015)... 2015 Vancouver personal injury lawyers at ... will now handle personal injury claims resulting due to ... rise, more and more people turn towards mass transportation ... needless suffering, serious injury and also deaths. , ... bus accident in BC you may have an ICBC ...
Breaking Medicine News(10 mins):Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2
... ... own the issue of “medication adherence.” , ... Alexandria, VA (Vocus) April 10, 2010 -- An article in ... fueling the National Association of Chain Drug Stores’ (NACDS) message that pharmacy’s role in ...
... Key Topics in Surgical Research and Methodology represents a ... an academic career. Four key elements are covered: ... Research as well as Recent Developments and Future Prospects ... "The aim of this book is to equip surgeons ...
... the United States has experienced a conflict with a ... care, researchers from the University of Chicago report in ... of General Internal Medicine . Younger and less ... than their older or more religious peers. Most primary ...
... say , FRIDAY, April 9 (HealthDay News) -- Doctors ... detect chronic liver disease in children, new research finds. ... (ALT) activity, is designed to detect liver disease or ... assessment of the test levels considered to be signs ...
... begin exercise program early recover faster, reduce sedative use, research ... patients in the intensive care unit may reduce their use ... exercise, a new study has found. , The amount of ... patients to exercise, which reduced the amount of muscle weakness ...
... ... was named a 2009 “Purveyor of the Year” by Outback Steakhouse Inc. (OSI) for ... custom, strategic learning solutions to help cascade strategies throughout its workforce to increase satisfaction ... ...
Cached Medicine News:Health News:New England Journal of Medicine Article Trumpets “Priority” Status of Helping Patients Take Medications Correctly 2Health News:New England Journal of Medicine Article Trumpets “Priority” Status of Helping Patients Take Medications Correctly 3Health News:Primary care physicians nationwide face clinical ethical conflicts with religious hospitals 2Health News:Liver Disease May Go Undetected in Children 2Health News:Mild Exercise Good for the Critically Ill 2Health News:Root Learning Named “Purveyor of the Year” For Strategic Partnership with Outback Steakhouse 2
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
... Utilizing technology developed over Guidants 20-year history, ... new foundation for successful treatment outcomes. It ... design with a lower profile shaft,more flexible ... you can cross tight and tortuous anatomy ...
... Utilizing technology developed over Guidants 20-year ... the new foundation for successful treatment outcomes. ... tip design with a lower profile shaft,more ... Now you can cross tight and tortuous ...
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of AFP in human serum or plasma....
Medicine Products: